---
title: Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38545827/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring
  highly malignant tumors. A 65-year-old man presented with a preauricular mass. After
  surgical treatment and histologic examination, the findings were interpreted as
  a squamous cell carcinoma (SCC) metastasis of the parotid gland deriving from a
  cancer of unknown primary DD primary SCC of the parotid gland. Adjuvant platinum-based
  radiochemotherapy was administered in domo. However, re-staging revealed ...
disable_comments: true
---
Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring highly malignant tumors. A 65-year-old man presented with a preauricular mass. After surgical treatment and histologic examination, the findings were interpreted as a squamous cell carcinoma (SCC) metastasis of the parotid gland deriving from a cancer of unknown primary DD primary SCC of the parotid gland. Adjuvant platinum-based radiochemotherapy was administered in domo. However, re-staging revealed ...